by Jessica Etheridge | Jul 30, 2024 | News and Events
Existing FDA-approved blood test for colorectal cancer screening, ColoHealth™, formerly known as Epi proColon. ColoHealth™ has been on the market since 2016 as the first and only FDA-approved blood test for colorectal cancer screening. Recently rebranded by New Day...
by Jessica Etheridge | Jul 15, 2024 | News and Events, Products & Pipeline, Research & Development
Mathias M. Petersen, Jakob Kleif, Jason Liggett, Morten Rasmussen, Lars N. Jørgensen, Jesper Vilandt, Jakob B. Seidelin, Carla M.T. Beertsen, Annemieke C. Heijboer, Claudia Jaensch, Peter Bondeven, Kåre A. Gotschalck, Uffe Schou Løve, Susan H. Gawel, Berit Andersen,...
by Jessica Etheridge | Mar 28, 2024 | News and Events
Download Episode As Colorectal Cancer Awareness Month 2024 comes to a close, Further Together host Michael Holtz, a 12-year survivor of stage IIIB colorectal cancer, talks to Eric Mayer and Jessica Etheridge, CEO and director of marketing and branding, respectively,...
by Jessica Etheridge | Mar 28, 2024 | News and Events
From Living East Tennessee KNOXVILLE, Tenn. (WATE) — March is National Colorectal Cancer Awareness Month and one group is bringing awareness to the significant development of a blood-test for colorectal cancer. This test is the first of its kind and will offer...
by Jessica Etheridge | Jan 3, 2024 | News and Events
From: Teknovation Author: Tom Ballard The long-term vision involves everything from R&D to commercialization with testing at the heart of the services the company will provide. The new year brings exciting new opportunities for New Day Diagnostics...
by Jessica Etheridge | Sep 14, 2023 | Company Details, News and Events
KNOXVILLE, Tenn., September 14, 2023–New Day Diagnostics is pleased to announce that the Extraordinary General Meeting of Epigenomics AG (Frankfurt General Standard: ECX1), a molecular diagnostics company focused on blood testing for the early detection of...
